Securities Registration: Employee Benefit Plan (s-8)
March 10 2017 - 4:10PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on March 10, 2017
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
ZAFGEN, INC.
(Exact
Name of Registrant as Specified in its Charter)
|
|
|
Delaware
|
|
20-3857670
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
Zafgen, Inc.
175 Portland Street, 4th Floor
Boston, Massachusetts 02114
(617) 622-4003
(Address
of Principal Executive Offices)
Zafgen, Inc. 2014 Stock Option and Incentive Plan
(Full Title of the Plans)
Thomas E. Hughes, Ph.D.
President and
Chief
Executive Officer
Zafgen, Inc.
175 Portland Street, 4th Floor
Boston, Massachusetts 02114
(Name and Address of Agent For Service)
Copy to:
Mitchell S. Bloom, Esq.
Laurie A. Burlingame, Esq.
Goodwin Procter LLP
100
Northern Avenue
Boston, Massachusetts 02210
(617) 570-1000
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting
company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☒
|
|
|
|
|
Non-accelerated filer
|
|
☐ (Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
☐
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of Securities
to be Registered
|
|
Amount
to be
Registered
(1)
|
|
Proposed
Maximum
Offering
Price
per Share
|
|
Proposed
Maximum
Aggregate
Offering Price
|
|
Amount of
Registration Fee
|
Common Stock, $0.001 par value per share
|
|
1,093,302 shares (2)
|
|
$3.86 (3)
|
|
$4,220,145.72
|
|
$489.12
|
|
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the Securities Act), this registration statement on Form S-8 (this Registration Statement) shall also cover any additional
shares of common stock, par value $0.001 per share (the Common Stock), of Zafgen, Inc. (the Registrant), which become issuable under the Registrants 2014 Stock Option and Incentive Plan (the Plan) by reason
of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrants outstanding shares of Common Stock.
|
(2)
|
Represents an automatic increase to the number of shares available for issuance under the Plan, effective January 1, 2017. Shares available for issuance under the Plan were previously registered on registration
statements on Form S-8 filed with the Securities and Exchange Commission on June 19, 2014 (Registration No. 333-196900), June 12, 2015 (Registration No. 333-204931) and March 15, 2016 (Registration No. 333-210216).
|
(3)
|
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act, and based on the average of the high and low sale prices of the Registrants Common Stock, as
quoted on the Nasdaq Global Select Market, on March 8, 2017.
|
EXPLANATORY NOTE
This Registration Statement on Form S-8 registers additional shares of Common Stock under the Registrants 2014 Stock Option and Incentive Plan (the
Plan). The number of shares of Common Stock reserved and available for issuance under the Plan is subject to an automatic annual increase on each January 1, beginning in 2015, by an amount equal to four percent of the number of
shares of Common Stock issued and outstanding on the immediately preceding December 31 or such lesser number of shares of Common Stock as determined by the Compensation Committee of the Registrants Board of Directors. Accordingly, on
January 1, 2017, the number of shares of Common Stock reserved and available for issuance under the plan increased by 1,093,302. This Registration Statement registers these additional 1,093,302 shares of Common Stock. The additional shares are
of the same class as other securities relating to the Plan for which the Registrants registration statement filed on Form S-8 (Registration Nos. 333-196900, 333-204931 and 333-210216) on June 19, 2014, June 12, 2015 and
March 15, 2016 are effective. The information contained in the Registrants registration statements on Form S-8 (Registration Nos. 333-196900, 333-204931 and 333-210216) is hereby incorporated by reference pursuant to General
Instruction E.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
See the Exhibit Index on the page
immediately preceding the exhibits for a list of exhibits filed as part of this registration statement, which Exhibit Index is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boston, Commonwealth of Massachusetts, on the 10th day of March,
2017.
|
|
|
ZAFGEN, INC.
|
|
|
By:
|
|
/s/ Thomas E. Hughes, Ph.D.
|
|
|
Thomas E. Hughes, Ph.D.
|
|
|
President and Chief Executive Officer
|
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL BY THESE PRESENT, that each individual whose signature appears below hereby constitutes and appoints each of Thomas E. Hughes, Ph.D. and Patricia L.
Allen as such persons true and lawful attorney-in-fact and agent with full power of substitution and resubstitution, for such person in such persons name, place and stead, in any and all capacities, to sign any and all amendments
(including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby
ratifying and confirming all that any said attorney-in-fact and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following person in the capacities
and on the date indicated.
|
|
|
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
/s/Thomas E. Hughes, Ph.D.
|
|
|
|
|
|
|
|
Thomas E. Hughes, Ph.D.
|
|
President, Chief Executive Officer, and Director
(Principal Executive Officer)
|
|
March 10, 2017
|
|
|
|
/s/ Patricia L. Allen
|
|
|
|
|
|
|
|
Patricia L. Allen
|
|
Chief Financial Officer
(Principal Financial
and
Accounting Officer)
|
|
March 10, 2017
|
|
|
|
/s/ Peter Barrett, Ph.D.
|
|
|
|
|
|
|
|
Peter Barrett, Ph.D.
|
|
Chairman of the Board of Directors
|
|
March 10, 2017
|
|
|
|
/s/ Bruce Booth, Ph.D.
Bruce Booth, Ph.D.
|
|
Director
|
|
March 10, 2017
|
|
|
|
/s/ Robert J. Perez
Robert J. Perez
|
|
Director
|
|
March 10, 2017
|
|
|
|
/s/ Frances K. Heller
Frances K. Heller
|
|
Director
|
|
March 10,2017
|
|
|
|
/s/ John L. LaMattina, Ph.D.
John L. LaMattina, Ph.D.
|
|
Director
|
|
March 10, 2017
|
|
|
|
/s/ Cameron Geoffrey McDonough, M.D.
Cameron Geoffrey McDonough, M.D.
|
|
Director
|
|
March 10, 2017
|
|
|
|
/s/ Frank E. Thomas
Frank E. Thomas
|
|
Director
|
|
March 10, 2017
|
|
|
|
/s/ Thomas O. Daniel, M.D.
Thomas O. Daniel, M.D.
|
|
Director
|
|
March 10, 2017
|
EXHIBIT INDEX
|
|
|
Exhibit
No.
|
|
Description
|
|
|
4.1
|
|
Form of Common Stock certificate of the registrant (Incorporated by reference to Exhibit 4.1 to the registrants Registration Statement on Form S-1, as amended (File No. 333-195391)).
|
|
|
4.2
|
|
Form of Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.2 to the registrants Registration Statement on Form S-1, as amended (File No. 333-195391)).
|
|
|
4.3
|
|
Form of Amended and Restated By-laws (Incorporated by reference to Exhibit 3.4 to the registrants Registration Statement on Form S-1, as amended (File No. 333-195391)).
|
|
|
4.4
|
|
Third Amended and Restated Investors Rights Agreement by and among the registrant and certain of its stockholders, dated as of November 25, 2013 (Incorporated by reference to Exhibit 4.2 to the registrants Registration
Statement on Form S-1, as amended (File No. 333-195391)).
|
|
|
5.1*
|
|
Opinion of Goodwin Procter LLP.
|
|
|
23.1*
|
|
Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.
|
|
|
23.2*
|
|
Consent of Goodwin Procter LLP (included in Exhibit 5.1).
|
|
|
24.1*
|
|
Power of attorney (included on signature page).
|
|
|
99.1
|
|
2014 Stock Option and Incentive Plan and forms of agreements thereunder (Incorporated by reference to Exhibit 10.2 to the registrants Registration Statement on Form S-1 (File No. 333-195391)).
|
Zafgen (NASDAQ:ZFGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zafgen (NASDAQ:ZFGN)
Historical Stock Chart
From Sep 2023 to Sep 2024